Dr. Theodore Friedman from Charles R. Drew University, Division of Endocrinology is currently seeking patients to participate in a research study of pituitary dysfunction.
Ages 18-55.
To Undergo Baseline Studies to Evaluate Consequences of Low Testosterone and
To Receive Testosterone Replacement for 2 Months.
Subjects Will Be Compensated.
Contact:
Dr. Friedman or Dr. Zuckerbraun
Charles R. Drew University - Clinical Research Center
1731 E. 120th Street
Los Angeles, CA 90059
Telephone: 323-563-9353
Email:
study@goodhormonehealth.com
Recruiting men with pituitary disease who have testosterone
and growth hormone deficiencies.
Recruiting men with pituitary disease who have testosterone
and growth hormone deficiencies.
Both testosterone and growth hormone individually improve bone density in men
who have deficiencies of these hormones. The purpose of this research study is
to determine if the combination of testosterone and growth hormone improves bone
structure more than testosterone alone.
Thirteen outpatient visits over a 2-year period are required. Bone structure
will be evaluated three times (at the beginning, after 12 months, and after 24
months). Three kinds of tests will be performed: DEXA, MRI and p-QCT. All three
are non-invasive tests of bone quality and low risk.
By participating in this study you will learn more about the health of your
bones and other aspects of your health. Reports will be provided to you and to
any physician you wish. The study covers the cost of all study procedures and
medications.
Study Criteria:
Be male and over 18 years of age
Have documented pituitary disease
Be deficient in testosterone and growth hormone
Have not taken growth hormone or testosterone within the past two years
Contact:
Helen Peachey, RN, Research Coordinator
University of Pennsylvania Health System
Department of Endocrinology
778 Clinical Research Bldg.
415 Curie Blvd.
Philadelphia, PA 19104
Telephone: 215-898-5664
Fax: 215-573-5809
Email:
peacheyh@mail.med.upenn.edu